Breaking News Instant updates and real-time market news.

CCL

Carnival

$28.14 /

+0.07 (+0.25%)

09:17
06/24/21
06/24
09:17
06/24/21
09:17

Carnival reports Q2 GAAP net loss of ($2.1B), adjusted net loss ($2B)

Second quarter 2021 ended with $9.3 billion of cash and short-term investments, which the company believes is sufficient liquidity to return to full cruise operations. Customer deposits increased in the second quarter of 2021 compared to the previous quarter. Cash burn rate in the first half of 2021 was better than forecasted primarily due to the timing of proceeds from ship sales and working capital changes. 42 ships from eight of the company's nine brands either have resumed or are announced to resume guest cruise operations by November 30, 2021, which is over 50% of the company's capacity, with more announcements expected in the coming weeks. Booking volumes for all future cruises during the second quarter of 2021 were 45% higher than booking volumes during the first quarter of 2021. Cumulative advanced bookings for full year 2022 are ahead of a very strong 2019, despite minimal advertising or marketing. Building on a legacy of ESG performance, the company announced its 2030 sustainability goals and 2050 sustainability aspirations, focusing strategically and holistically on enhancing its sustainable business model while reinforcing its commitment to and investment in sustainability solutions. The company repriced its first-priority senior secured term loan facility, reducing its future annual interest expense by over $120 million per year and has approval in principle from the relevant export credit agencies to defer approximately $1.0 billion of principal payments, increasing its near term liquidity. The company expects these transactions to close during the third quarter of 2021 and continues to focus on pursuing additional refinancing opportunities to reduce interest rates and extend maturities.

  • 24

    Jun

  • 23

    Feb

CCL Carnival
$28.14 /

+0.07 (+0.25%)

06/17/21 JPMorgan
Carnival price target raised to $36 from $33 at JPMorgan
06/16/21 Wolfe Research
Wolfe upgrades 'Big 3' cruise stocks on improving booking momentum
06/16/21 Wolfe Research
Carnival upgraded to Outperform from Peer Perform at Wolfe Research
06/11/21 Credit Suisse
Royal Caribbean selloff on Covid cases an opportunity, says Credit Suisse

TODAY'S FREE FLY STORIES

Earnings
Golden Entertainment reports Q2 EPS $3.26, consensus 49c » 17:03
08/05/21
08/05
17:03
08/05/21
17:03
GDEN

Golden Entertainment

$47.31 /

+2.67 (+5.98%)

Reports Q2 revenue $292M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GDEN Golden Entertainment
$47.31 /

+2.67 (+5.98%)

05/07/21 B. Riley
Golden Entertainment price target raised to $60 from $48 at B. Riley
05/07/21 Deutsche Bank
Golden Entertainment price target raised to $42 from $34 at Deutsche Bank
05/07/21 Macquarie
Golden Entertainment price target raised to $50 from $43 at Macquarie
04/27/21 B. Riley
Golden Entertainment initiated with a Buy at B. Riley
GDEN Golden Entertainment
$47.31 /

+2.67 (+5.98%)

GDEN Golden Entertainment
$47.31 /

+2.67 (+5.98%)

Earnings
Chembio Diagnostics reports Q2 EPS (45c), consensus (27c) » 17:02
08/05/21
08/05
17:02
08/05/21
17:02
CEMI

Chembio Diagnostics

$3.52 /

+0.105 (+3.08%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CEMI Chembio Diagnostics
$3.52 /

+0.105 (+3.08%)

CEMI Chembio Diagnostics
$3.52 /

+0.105 (+3.08%)

07/22/21 Benchmark
Chembio's Ethiopia order factored in estimates, says Benchmark
07/21/21 Colliers
Colliers downgrades Chembio Diagnostics, says current price 'too aggressive'
07/21/21 Colliers
Chembio Diagnostics downgraded to Neutral from Buy at Colliers
12/03/20 Craig-Hallum
Chembio Diagnostics upgraded to Buy at Craig-Hallum
CEMI Chembio Diagnostics
$3.52 /

+0.105 (+3.08%)

CEMI Chembio Diagnostics
$3.52 /

+0.105 (+3.08%)

CEMI Chembio Diagnostics
$3.52 /

+0.105 (+3.08%)

Earnings
ITT raises FY21 adjusted EPS view to $3.90-$4.05 from $3.80-$4.00  17:02
08/05/21
08/05
17:02
08/05/21
17:02
ITT

ITT

$97.96 /

+0.89 (+0.92%)

Consensus $3.97.

ShowHide Related Items >><<
ITT ITT
$97.96 /

+0.89 (+0.92%)

ITT ITT
$97.96 /

+0.89 (+0.92%)

06/15/21 Citi
ITT initiated with a Buy at Citi
05/13/21 Gordon Haskett
Gordon Haskett downgrades ITT on valuation, high expectations
05/13/21 Gordon Haskett
ITT downgraded to Hold from Buy at Gordon Haskett
05/10/21 UBS
ITT downgraded to Neutral from Buy on valuation at UBS
ITT ITT
$97.96 /

+0.89 (+0.92%)

Earnings
BigCommerce sees FY21 revenue 210.7M-$211.7M, consensus $197.67M  17:02
08/05/21
08/05
17:02
08/05/21
17:02
BIGC

BigCommerce

$71.36 /

+2.16 (+3.12%)

 
ShowHide Related Items >><<
BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

07/28/21 Needham
BigCommerce price target raised to $85 from $60 at Needham
07/23/21 Barclays
BigCommerce price target raised to $66 from $53 at Barclays
07/20/21 William Blair
New partnerships align with BigCommerce open SaaS strategy, says William Blair
07/07/21 Piper Sandler
Piper says integration with Amazon MFC strengthens BigCommerce bull case
BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

  • 13
    Nov
BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

Earnings
Corteva reports Q2 adjusted EPS $1.40, consensus $1.26 » 17:02
08/05/21
08/05
17:02
08/05/21
17:02
CTVA

Corteva

$41.44 /

-0.87 (-2.06%)

Reports Q2 revenue $5.6B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTVA Corteva
$41.44 /

-0.87 (-2.06%)

CTVA Corteva
$41.44 /

-0.87 (-2.06%)

06/24/21 Deutsche Bank
Corteva shares could rise 50% by end of 2023, says Deutsche Bank
05/26/21 JPMorgan
Corteva shares have been 'over-penalized,' says JPMorgan
05/17/21 Argus
Corteva price target raised to $54 from $51 at Argus
05/10/21 BofA
Corteva double downgraded to Underperform at BofA on litigation risks
CTVA Corteva
$41.44 /

-0.87 (-2.06%)

CTVA Corteva
$41.44 /

-0.87 (-2.06%)

Earnings
ITT reports Q2 adjusted EPS 94c, consensus 90c » 17:02
08/05/21
08/05
17:02
08/05/21
17:02
ITT

ITT

$97.96 /

+0.89 (+0.92%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITT ITT
$97.96 /

+0.89 (+0.92%)

ITT ITT
$97.96 /

+0.89 (+0.92%)

06/15/21 Citi
ITT initiated with a Buy at Citi
05/13/21 Gordon Haskett
Gordon Haskett downgrades ITT on valuation, high expectations
05/13/21 Gordon Haskett
ITT downgraded to Hold from Buy at Gordon Haskett
05/10/21 UBS
ITT downgraded to Neutral from Buy on valuation at UBS
ITT ITT
$97.96 /

+0.89 (+0.92%)

Earnings
BigCommerce Sees Q3 revenue $ $54.5M-$55M, consensus $49.88M  17:01
08/05/21
08/05
17:01
08/05/21
17:01
BIGC

BigCommerce

$71.36 /

+2.16 (+3.12%)

 
ShowHide Related Items >><<
BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

07/28/21 Needham
BigCommerce price target raised to $85 from $60 at Needham
07/23/21 Barclays
BigCommerce price target raised to $66 from $53 at Barclays
07/20/21 William Blair
New partnerships align with BigCommerce open SaaS strategy, says William Blair
07/07/21 Piper Sandler
Piper says integration with Amazon MFC strengthens BigCommerce bull case
BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

  • 13
    Nov
BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

Earnings
Arcutis Biotherapeutics reports Q2 EPS (84c), consensus (90c) » 17:00
08/05/21
08/05
17:00
08/05/21
17:00
ARQT

Arcutis Biotherapeutics

$21.74 /

+0.89 (+4.27%)

Cash, cash equivalents,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARQT Arcutis Biotherapeutics
$21.74 /

+0.89 (+4.27%)

ARQT Arcutis Biotherapeutics
$21.74 /

+0.89 (+4.27%)

06/29/21 Mizuho
Arcutis Biotherapeutics initiated with a Buy at Mizuho
05/27/21 Morgan Stanley
Arcutis Biotherapeutics initiated with an Overweight at Morgan Stanley
02/02/21 Truist
Arcutis Biotherapeutics price target raised to $48 from $38 at Truist
02/01/21 Cowen
Arcutis Biotherapeutics price target raised to $80 from $55 at Cowen
ARQT Arcutis Biotherapeutics
$21.74 /

+0.89 (+4.27%)

  • 03
    Feb
  • 02
    Oct
ARQT Arcutis Biotherapeutics
$21.74 /

+0.89 (+4.27%)

Earnings
MP Materials reports Q2 EPS 15c, consensus 13c » 17:00
08/05/21
08/05
17:00
08/05/21
17:00
MP

MP Materials

$36.10 /

+0.48 (+1.35%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MP MP Materials
$36.10 /

+0.48 (+1.35%)

MP MP Materials
$36.10 /

+0.48 (+1.35%)

07/23/21
Fly Intel: Top five analyst initiations
07/23/21 DA Davidson
MP Materials initiated with a Buy at DA Davidson
06/29/21 Baird
Baird starts MP Materials at Outperform, sees 'superior multiple' warranted
06/29/21 Baird
MP Materials initiated with an Outperform at Baird
MP MP Materials
$36.10 /

+0.48 (+1.35%)

  • 24
    Mar
MP MP Materials
$36.10 /

+0.48 (+1.35%)

MP MP Materials
$36.10 /

+0.48 (+1.35%)

MP MP Materials
$36.10 /

+0.48 (+1.35%)

Earnings
B&G Foods backs FY21 revenue view of $2.05B-$2.10B, consensus $2.16B » 17:00
08/05/21
08/05
17:00
08/05/21
17:00
BGS

B&G Foods

$28.18 /

+0.19 (+0.68%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

03/22/21
Fly Intel: Top five analyst downgrades
03/22/21 Piper Sandler
B&G Foods downgraded to Neutral from Overweight at Piper Sandler
03/03/21 RBC Capital
B&G Foods price target lowered to $29 from $32 at RBC Capital
01/19/21 Stephens
B&G Foods initiated with an Equal Weight at Stephens
BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

Earnings
Livent raises FY21 revenue view to $370M-$390M from $335M-$365M » 16:59
08/05/21
08/05
16:59
08/05/21
16:59
LTHM

Livent

$20.38 /

+1.19 (+6.20%)

Consensus for FY21…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LTHM Livent
$20.38 /

+1.19 (+6.20%)

04/19/21
Fly Intel: Top five analyst upgrades
04/19/21 Evercore ISI
Evercore 'all in on lithium producers,' upgrades Livent to Outperform
04/19/21 Evercore ISI
Livent upgraded to Outperform from In Line at Evercore ISI
03/15/21 Credit Suisse
Livent assumed with a Neutral at Credit Suisse
LTHM Livent
$20.38 /

+1.19 (+6.20%)

  • 11
    Jun
LTHM Livent
$20.38 /

+1.19 (+6.20%)

Earnings
B&G Foods reports Q2 EPS 41c, consensus 49c » 16:59
08/05/21
08/05
16:59
08/05/21
16:59
BGS

B&G Foods

$28.18 /

+0.19 (+0.68%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

03/22/21
Fly Intel: Top five analyst downgrades
03/22/21 Piper Sandler
B&G Foods downgraded to Neutral from Overweight at Piper Sandler
03/03/21 RBC Capital
B&G Foods price target lowered to $29 from $32 at RBC Capital
01/19/21 Stephens
B&G Foods initiated with an Equal Weight at Stephens
BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

Earnings
BigCommerce reports Q2 EPS (6c), consensus (11c) » 16:59
08/05/21
08/05
16:59
08/05/21
16:59
BIGC

BigCommerce

$71.36 /

+2.16 (+3.12%)

Reports Q revenue $49M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

07/28/21 Needham
BigCommerce price target raised to $85 from $60 at Needham
07/23/21 Barclays
BigCommerce price target raised to $66 from $53 at Barclays
07/20/21 William Blair
New partnerships align with BigCommerce open SaaS strategy, says William Blair
07/07/21 Piper Sandler
Piper says integration with Amazon MFC strengthens BigCommerce bull case
BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

  • 13
    Nov
BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

Earnings
Magnite reports Q2 adjusted EPS 11c, consensus 12c » 16:59
08/05/21
08/05
16:59
08/05/21
16:59
MGNI

Magnite

$30.70 /

+1.08 (+3.65%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MGNI Magnite
$30.70 /

+1.08 (+3.65%)

MGNI Magnite
$30.70 /

+1.08 (+3.65%)

07/13/21 Stifel
Tremor International initiated with a Buy at Stifel
07/02/21 Craig-Hallum
Craig-Hallum says Magnite SpringServe deal more consequential than price implies
06/25/21 Macquarie
Google cookie delay removes near-term overhang on adtech, says Macquarie
06/11/21 Stephens
Magnite partnerships can help accelerate shift in spend to CTV, says Stephens
MGNI Magnite
$30.70 /

+1.08 (+3.65%)

MGNI Magnite
$30.70 /

+1.08 (+3.65%)

MGNI Magnite
$30.70 /

+1.08 (+3.65%)

Hot Stocks
Appian acquires Lana Labs, terms not disclosed » 16:59
08/05/21
08/05
16:59
08/05/21
16:59
APPN

Appian

$111.98 /

+2.22 (+2.02%)

Appian announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APPN Appian
$111.98 /

+2.22 (+2.02%)

08/02/21 Truist
Appian price target lowered to $120 from $205 at Truist
05/25/21
Fly Intel: Top five analyst upgrades
05/25/21 Macquarie
Appian upgraded to Neutral after share correction at Macquarie
05/25/21 Macquarie
Appian upgraded to Neutral from Underperform at Macquarie
APPN Appian
$111.98 /

+2.22 (+2.02%)

Hot Stocks
Covetrus backs FY21 adjusted EBITDA view of $245M-$255M  16:58
08/05/21
08/05
16:58
08/05/21
16:58
CVET

Covetrus

$25.41 /

+0.475 (+1.90%)

 
ShowHide Related Items >><<
CVET Covetrus
$25.41 /

+0.475 (+1.90%)

CVET Covetrus
$25.41 /

+0.475 (+1.90%)

08/04/21 Credit Suisse
Covetrus assumed with a Neutral at Credit Suisse
07/12/21 Guggenheim
Covetrus upgraded to Buy from Neutral at Guggenheim
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Barclays
Covetrus initiated with an Overweight at Barclays
CVET Covetrus
$25.41 /

+0.475 (+1.90%)

Hot Stocks
Air Transport Services sees FY21 CapEx $550M » 16:58
08/05/21
08/05
16:58
08/05/21
16:58
ATSG

Air Transport Services

$25.42 /

+0.53 (+2.13%)

The company said:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

06/21/21 Stifel
Air Transport Services resumed with a Buy at Stifel
10/12/20 Loop Capital
Air Transport Services upgraded to Buy from Hold at Loop Capital
ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

Earnings
Livent reports Q2 adjusted EPS 4c, consensus 2c » 16:58
08/05/21
08/05
16:58
08/05/21
16:58
LTHM

Livent

$20.38 /

+1.19 (+6.20%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LTHM Livent
$20.38 /

+1.19 (+6.20%)

04/19/21
Fly Intel: Top five analyst upgrades
04/19/21 Evercore ISI
Evercore 'all in on lithium producers,' upgrades Livent to Outperform
04/19/21 Evercore ISI
Livent upgraded to Outperform from In Line at Evercore ISI
03/15/21 Credit Suisse
Livent assumed with a Neutral at Credit Suisse
LTHM Livent
$20.38 /

+1.19 (+6.20%)

  • 11
    Jun
LTHM Livent
$20.38 /

+1.19 (+6.20%)

Earnings
Covetrus reports Q2 adjusted EBITDA $66M vs. $63M last year » 16:58
08/05/21
08/05
16:58
08/05/21
16:58
CVET

Covetrus

$25.41 /

+0.475 (+1.90%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVET Covetrus
$25.41 /

+0.475 (+1.90%)

CVET Covetrus
$25.41 /

+0.475 (+1.90%)

08/04/21 Credit Suisse
Covetrus assumed with a Neutral at Credit Suisse
07/12/21 Guggenheim
Covetrus upgraded to Buy from Neutral at Guggenheim
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Barclays
Covetrus initiated with an Overweight at Barclays
CVET Covetrus
$25.41 /

+0.475 (+1.90%)

Earnings
Air Transport Services reports Q2 adjusted EPS 35c, consensus 27c » 16:58
08/05/21
08/05
16:58
08/05/21
16:58
ATSG

Air Transport Services

$25.42 /

+0.53 (+2.13%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

06/21/21 Stifel
Air Transport Services resumed with a Buy at Stifel
10/12/20 Loop Capital
Air Transport Services upgraded to Buy from Hold at Loop Capital
ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

Hot Stocks
MEI Pharma CFO Brian Drazba to retire at end of 2021 » 16:58
08/05/21
08/05
16:58
08/05/21
16:58
MEIP

MEI Pharma

$2.66 /

+0.04 (+1.53%)

MEI Pharma announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MEIP MEI Pharma
$2.66 /

+0.04 (+1.53%)

MEIP MEI Pharma
$2.66 /

+0.04 (+1.53%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
MEIP MEI Pharma
$2.66 /

+0.04 (+1.53%)

Earnings
Aligos Therapeutics reports Q2 EPS (79c), consensus (81c) » 16:57
08/05/21
08/05
16:57
08/05/21
16:57
ALGS

Aligos Therapeutics

$16.31 /

+0.85 (+5.50%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

07/08/21 Piper Sandler
Aligos should be bought into 'catalyst rich' second half, says Piper Sandler
06/21/21 Piper Sandler
Aligos reported 'robust data' in hepatitis B virus, says Piper Sandler
06/10/21 Piper Sandler
Aligos Therapeutics has data-rich month with robust lineup, says Piper Sandler
05/17/21 Piper Sandler
Aligos Therapeutics assumed with an Overweight at Piper Sandler
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

  • 01
    Jul
  • 16
    Oct
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

Earnings
Aligos Therapeutics reports Q2 EPS (79c), consensus (81c) » 16:57
08/05/21
08/05
16:57
08/05/21
16:57
ALGS

Aligos Therapeutics

$16.31 /

+0.85 (+5.50%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

07/08/21 Piper Sandler
Aligos should be bought into 'catalyst rich' second half, says Piper Sandler
06/21/21 Piper Sandler
Aligos reported 'robust data' in hepatitis B virus, says Piper Sandler
06/10/21 Piper Sandler
Aligos Therapeutics has data-rich month with robust lineup, says Piper Sandler
05/17/21 Piper Sandler
Aligos Therapeutics assumed with an Overweight at Piper Sandler
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

  • 01
    Jul
  • 16
    Oct
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

Earnings
Aligos Therapeutics reports Q2 EPS (79c), consensus (81c) » 16:57
08/05/21
08/05
16:57
08/05/21
16:57
ALGS

Aligos Therapeutics

$16.31 /

+0.85 (+5.50%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

07/08/21 Piper Sandler
Aligos should be bought into 'catalyst rich' second half, says Piper Sandler
06/21/21 Piper Sandler
Aligos reported 'robust data' in hepatitis B virus, says Piper Sandler
06/10/21 Piper Sandler
Aligos Therapeutics has data-rich month with robust lineup, says Piper Sandler
05/17/21 Piper Sandler
Aligos Therapeutics assumed with an Overweight at Piper Sandler
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

  • 01
    Jul
  • 16
    Oct
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

Earnings
Envestnet sees FY21 adjusted EPS $2.30-$2.35, consensus $2.14 » 16:57
08/05/21
08/05
16:57
08/05/21
16:57
ENV

Envestnet

$74.53 /

+0.23 (+0.31%)

Sees FY21 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENV Envestnet
$74.53 /

+0.23 (+0.31%)

ENV Envestnet
$74.53 /

+0.23 (+0.31%)

07/22/21 Jefferies
Envestnet downgraded to Underperform from Buy at Jefferies
05/13/21 Truist
Envestnet price target lowered to $85 from $95 at Truist
04/06/21 Jefferies
Jefferies sees Envestnet slightly beating guidance in Q1
02/26/21 RBC Capital
Envestnet price target lowered to $79 from $96 at RBC Capital
ENV Envestnet
$74.53 /

+0.23 (+0.31%)

ENV Envestnet
$74.53 /

+0.23 (+0.31%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.